Concepedia

Lawrence Davies

LD

Statistics

Publications

24

Citations

1.1K

H-Index

21

Active since

1986

Affiliations

Institute of Cancer Research(Current)

Cancer Research UK

University of Manchester

Cancer Research UK Manchester Institute

Evotec (United Kingdom)

Lawrence Davies is an author at Institute of Cancer Research specializing in pharmacy, molecular oncology, and medicinal chemistry.

ORCID

Publications per year

1986–2020

24

Publications

24

Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma

María Romina Girotti, Filipa M. Lopes, Natasha Preece et al. · Cancer Cell · 2014 · 209 citations · Full text

, , +17

Attenuated <i>Salmonella</i> Targets Prodrug Activating Enzyme Carboxypeptidase G2 to Mouse Melanoma and Human Breast and Colon Carcinomas for Effective Suicide Gene Therapy

Frank Friedlos, Panos Lehouritis, Lesley Ogilvie et al. · Clinical Cancer Research · 2008 · 90 citations · Full text

, , +14

Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships

Leo Leung, Dan Niculescu‐Duvaz, Deborah A. Smithen et al. · Journal of Medicinal Chemistry · 2019 · 70 citations · Full text

, , +15

Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.

RB Pedley, Shreya Sharma, G Boxer et al. · PubMed · 1999 · 60 citations

, , +16

Novel Inhibitors of B-RAF Based on a Disubstituted Pyrazine Scaffold. Generation of a Nanomolar Lead

Ion Niculescu‐Duvaz, Esteban Román, Steven R. Whittaker et al. · Journal of Medicinal Chemistry · 2005 · 52 citations · Full text

, , +13

1–5 of 24